Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis

Table 2

The potential kernel miRNAs selected by FZHY and Placebo treatments.

Group A (FZHY related miRNAs)				Group B (Placebo related miRNAs)
has-miR-1207-5p	has-miR-765	hsa-miR-19b-3p	hsa-miR-320d	hsa-miR-101-3p	hsa-miR-301b
has-miR-1268a	hsa-miR-101-3p	hsa-miR-21-5p	hsa-miR-340-5p	hsa-miR-1299	hsa-miR-335-5p
has-miR-134	hsa-miR-103a-3p	hsa-miR-221-3p	hsa-miR-374a-5p	hsa-miR-130a-3p	hsa-miR-33a-5p
has-miR-135a-3p	hsa-miR-128	hsa-miR-25-3p	hsa-miR-374b-5p	hsa-miR-142-3p	hsa-miR-340-5p
has-miR-1471	hsa-miR-142-5p	hsa-miR-26b-5p	hsa-miR-424-5p	hsa-miR-148b-3p	hsa-miR-363-3p
has-miR-26a-5p	hsa-miR-15a-5p	hsa-miR-27b-3p	hsa-miR-93-5p	hsa-miR-16-5p	hsa-miR-381-3p
has-miR-483-5p	hsa-miR-186-5p	hsa-miR-29c-3p		hsa-miR-19b-3p	hsa-miR-410
has-miR-663a	hsa-miR-19a-3p	hsa-miR-30e-3p		hsa-miR-21-5p	hsa-miR-497-5p